BMY · Annual Report (Form 10-K) · Filed February 11, 2026

Bristol Myers Squibb Co — 10-K exhibit

bmy-20251231exhibit22.htm

Bristol Myers Squibb Co on Boardroom Alpha

Document

EXHIBIT 22

Subsidiary Issuers of Guaranteed Securities

As of December 31, 2025, Bristol-Myers Squibb Company (Parent Guarantor) was the unconditional and irrevocable guarantor of the following unsecured registered notes issued by a wholly-owned subsidiary of Parent Guarantor:


Name of Subsidiary Issuer	State of Formation of Issuer	Description of Registered Notes
BMS Ireland Capital Funding Designated Activity Company	Ireland	2.973% Notes due 2030
BMS Ireland Capital Funding Designated Activity Company	Ireland	3.363% Notes due 2033
BMS Ireland Capital Funding Designated Activity Company	Ireland	3.857% Notes due 2038
BMS Ireland Capital Funding Designated Activity Company	Ireland	4.289% Notes due 2045
BMS Ireland Capital Funding Designated Activity Company	Ireland	4.581% Notes due 2055

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer